The publication record
Read the claim at its actual scope.
How Beyond the Tablet checks formulation wording, distinguishes primary sources and limits the claims its reviews make.
Different records answer different questions
A provider page establishes what the company describes publicly. A terminology source defines a word. An approved finished-product label addresses that specific product. None of those records alone identifies the contents or complete instructions of an individual compounded prescription.
Preserve the missing detail
We retain unresolved wording, incomplete formulation information and different billing or service descriptions when the public record does not settle them. A disagreement in public terminology is not evidence that a dispensed medicine is defective, nor permission to infer how it should be used.
Keep exact-product evidence separate
An ingredient’s history does not establish the safety or effectiveness of a combination containing it. A different dosage form or route can raise questions that ingredient familiarity cannot answer. Compounded drugs are not FDA approved, and professional involvement does not replace finished-product evidence.
Document the check, not a guarantee
The visible date records when public sources were checked. Advertised terms can change. We did not complete patient questionnaires, receive medication, test preparation quality or verify clinical outcomes. Articles use the publication’s editorial identity and do not claim medical review that did not occur.
Keep commercial placement legible
CoreAge’s first position is a disclosed commercial arrangement. We do not present it as a clinical score, a result of patient testing or a universal best choice. Original documents, context links and related reading let readers examine the basis and limits of each article.